Dr. Mahadevan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7979 Wurzbach Rd
San Antonio, TX 78229Phone+1 210-450-1143Fax+1 210-450-0407
Education & Training
- (King's College London - School of Medicine)Class of 1990, MD
- Birkbeck College University of LondonPh.D., Protein Crystallography, 1982 - 1986
- University of ReadingB.Sc., Physiology and Biochemistry with Chemistry, Honors, 1979 - 1982
- University of ConnecticutResidency, Internal Medicine
- National Institutes of Health Clinical CenterFellowship, Medical Oncology
Certifications & Licensure
- TX State Medical License 2020 - 2025
- AZ State Medical License 2002 - 2021
- TN State Medical License 2012 - 2017
- MS State Medical License 2013 - 2016
- CT State Medical License 1998 - 2003
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Dane Foundation Fellowship British Medical Council
- National Academy of Inventors Senior Member National Academy of Inventors, 2019
- Resistance mechanisms in HER2+ breast Cancer Flinn Foundation Award, 2017-2019
- Join now to see all
Clinical Trials
Publications & Presentations
PubMed
- 8 citationsBotensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.Andrea J Bullock, Benjamin L Schlechter, Marwan G Fakih, Apostolia M Tsimberidou, Joseph E Grossman
Nature Medicine. 2024-09-01 - Aurkin-A, a TPX2-Aurora A small molecule inhibitor disrupts Alisertib-induced polyploidy in aggressive diffuse large B cell lymphoma.Patrick J Conway, Bárbara De La Peña Avalos, Jonathan Dao, Sebastian Montagnino, Dmytro Kovalskyy
Neoplasia. 2024-09-01 - Gene Expression Patterns Associated with Survival in Glioblastoma.Christopher Morrison, Eric Weterings, Nicholas Gravbrot, Michael Hammer, Martin Weinand
International Journal of Molecular Sciences. 2024-03-25
Professional Memberships
- Member
- Member
- Member
- Southwest Oncology Group (SWOG)Member
- Early Therapeutic Committee (Liaison) – SWOG Lymphoma CommitteeMember
- Memphis Medical SocietyMember
- Molecular Cancer Therapeutics – Editorial BoardMember
- Astex Therapeutics – Scientific AdvisorMember
- SuperGen Pharmaceuticals, Inc. – Scientific AdvisorMember
- Current Medicinal Chemistry – Editorial board (Anti-cancer Drug Design)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: